Attenuatumione H
Attenuatumione H is a polycyclic polyprenylated acylphloroglucinol compound found in the whole plant of Hypericum attenuatum, and it exhibits antitumor activity. Attenuatumione H exerts cytotoxic effects on liver cancer cells and breast cancer cells. Attenuatumione H shows no significant inhibitory effect on LPS-induced NO production in macrophages and displays no significant cytotoxic activity against osteosarcoma cells. Attenuatumione H can be used in cancer research.
For research use only. We do not sell to patients.
- CAS No.: 2172833-78-0
- Formula: C35H54O7
- Molecular Weight:586.80
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
9.11 mM
|
Cytotoxicity against human hepatocellular carcinoma Hep-G2 cells incubated for 48 h measured by MTT assay.
Cytotoxicity against human hepatocellular carcinoma Hep-G2 cells incubated for 48 h measured by MTT assay.
|
S187439001630012X |
| MCF7 | IC50 |
16.24 mM
|
Cytotoxicity against human breast adenocarcinoma MCF-7 cells incubated for 48 h measured by MTT assay.
Cytotoxicity against human breast adenocarcinoma MCF-7 cells incubated for 48 h measured by MTT assay.
|
S187439001630012X |
| U2OS | IC50 |
>50 mM
|
Cytotoxicity against human osteosarcoma U2OS cells incubated for 48 h measured by MTT assay.
Cytotoxicity against human osteosarcoma U2OS cells incubated for 48 h measured by MTT assay.
|
S187439001630012X |
| RAW264.7 | IC50 |
>50 mM
|
Inhibition of nitric oxide production in lipopolysaccharide-stimulated RAW264.7 mouse macrophage cells.
Inhibition of nitric oxide production in lipopolysaccharide-stimulated RAW264.7 mouse macrophage cells.
|
S187439001630012X |
In Vitro
Attenuatumione H (compound 2) (48 h) exhibits moderate cytotoxicity against Hep-G2 (IC50 = 9.11 mM) and MCF-7 (IC50 = 16.24 mM) cell lines, but shows no activity against U2OS cells (IC50 > 50 mM)[1].
Attenuatumione H does not inhibit nitric oxide production in lipopolysaccharide-stimulated RAW264.7 cells at concentrations up to 50 mM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2172833-78-0
-
Molecular Weight 586.80
-
Formula C35H54O7
-
SMILES
CC(C)C([C@]12C3=C(C[C@H](C(C)(O3)C)O)C([C@](C1=O)(C[C@@H]([C@@]2(C)CC/C=C(C)/C)C/C=C(C)\C)C[C@H](O)C(C)(O)C)=O)=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)